The shift from volume to value requires more than enthusiasm. It requires engineering discipline, business ownership and the ...

Rhythm Biosciences (ASX:RHY) has inked an exploratory collaboration with US-based datma to evaluate how its datma.FED ...

Topline data were announced from a phase 3 trial evaluating varegacestat in patients with progressing desmoid tumors.

At the core of every AI coding agent is a technology called a large language model (LLM), which is a type of neural network ...

MUSCAT: The University of Technology and Applied Sciences (UTAS) has released the second issue of its quarterly magazine ...

An interactive toolbox for standardizing, validating, simulating, reducing, and exploring detailed biophysical models that can be used to reveal how morpho-electric properties map to dendritic and ...

This study provides important evidence that negative affect is associated with slower cognitive processing in daily life, with findings replicated across three independent samples and supported by ...

Neurosense Therapeutics Ltd. ( ($NRSN) ) has shared an announcement. On December 22, 2025, NeuroSense Therapeutics reported that a safety analysis ...

South Korea: In a post hoc analysis of the randomized PULSAR trial, aflibercept 8 mg demonstrated noninferior visual outcomes ...

A new Harvard study shows how lithium, one of the simplest elements, may protect against and even reverse Alzheimer’s — and ...

As an exploratory proof-of-concept study, clinical outcome measures are descriptive by design. NeuroSense will analyze clinical observations alongside biomarker data to enable a more comprehensive ...